Answers are grounded in this paper and cite their sources.
Case report reveals successful targeted combination therapy for severe Nocardia farcinica necrotizing pneumonia in an immunocompetent host, highlighting the importance of rapid MALDI-TOF diagnosis.
Nocardiosis is a rare, serious infection caused by Nocardia species, primarily affecting immunocompromised individuals. It commonly presents as pulmonary disease, often mimicking tuberculosis or bacterial pneumonia. Nocardia farcinica , although less common than Nocardia asteroides , is notably aggressive, multidrug-resistant, and linked to disseminated disease and high morbidity. We report necrotizing pneumonia caused by N. farcinica in a 74-year-old woman without major immunosuppression, with only controlled diabetes and hypertension as comorbidities. She presented with a 20-day history of fever and productive cough, progressing to moderate obtundation (GCS 9 to 12). Diagnosis was established through endotracheal aspirate culture with Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) identification after 6 to 7 days of admission. Targeted combination therapy with intravenous imipenem-cilastatin, intravenous amikacin, and oral trimethoprim-sulfamethoxazole (TMP-SMX) led to complete clinical, neurological, and radiological resolution at 6 months.
No takes yet. Share an insight, caveat, or question.
Vats et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: